Tumors were significantly larger (Figure 3E) and heavier (Figure 3F) in the control group than in the USP42-knockdown group, indicating that suppression of USP42 significantly inhibited PCa tumor growth in vivo. Here, USP42 is linked to posterior cortical atrophy.